|
Category | FY | Funding IC | Project Number | Sub Project # | Project Title | PI Name | Org Name | State / Country | Amount |
Multiple Sclerosis
|
2015
|
NIAID
|
5R01AI053147-11
|
|
PKC-theta function in RORgammat-regulated Th17 differentiation
|
SUN, ZUOMING
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
CA
|
$415,000
|
Multiple Sclerosis
|
2015
|
NIAID
|
5R01AI093718-04
|
|
Novel Functions of S1P in Neuroinflammation
|
KORDULA, TOMASZ
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
VA
|
$373,750
|
Multiple Sclerosis
|
2015
|
NIAID
|
5R01AI093881-04
|
|
Inducible B-regulatory cells (iBREGs) for treatment of Multiple Sclerosis
|
GALIPEAU, JACQUES
|
EMORY UNIVERSITY
|
GA
|
$387,500
|
Multiple Sclerosis
|
2015
|
NIAID
|
5R01AI040614-17
|
|
In vivo role of CTLA-4 in Costimulation and Autoimmunity
|
SHARPE, ARLENE
|
HARVARD MEDICAL SCHOOL
|
MA
|
$423,750
|
Multiple Sclerosis
|
2015
|
NIAID
|
5R01AI103867-02
|
|
Structural correlates of T cell receptor signaling
|
GARCIA, KENAN
|
STANFORD UNIVERSITY
|
CA
|
$451,752
|
Multiple Sclerosis
|
2015
|
NEI
|
5R21EY024036-02
|
|
Quantitative Image Analysis Techniques for Optic Nerve Disease
|
LANDMAN, BENNETT
|
VANDERBILT UNIVERSITY
|
TN
|
$185,147
|
Multiple Sclerosis
|
2015
|
NINDS
|
5R01NS079796-03
|
|
Gamma-Secretase and Myelin: A Paradigm Shift in Brain Disorders
|
YU, GANG
|
UT SOUTHWESTERN MEDICAL CENTER
|
TX
|
$347,813
|
Multiple Sclerosis
|
2015
|
NIGMS
|
5SC1GM095426-04
|
|
Role of CX3CR1 in adaptive immunity during autoimmune encephalomyelitis
|
CARDONA, ASTRID
|
UNIVERSITY OF TEXAS SAN ANTONIO
|
TX
|
$294,000
|
Multiple Sclerosis
|
2015
|
NIAID
|
1R13AI114057-01
|
|
Autoimmunity and Tolerance
|
WOODLAND, DAVID
|
KEYSTONE SYMPOSIA
|
CO
|
$8,000
|
Multiple Sclerosis
|
2015
|
NEI
|
5R01EY022936-03
|
|
Humoral Immunity, Astrocyte Injury, and Demyelination in Neuromyelitis Optica
|
BENNETT, JEFFREY
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$380,362
|
Multiple Sclerosis
|
2015
|
NINDS
|
5R01NS075066-04
|
|
Bayesian Spatial Point Process Modeling of Neuroimage Data
|
JOHNSON, TIMOTHY
|
UNIVERSITY OF MICHIGAN
|
MI
|
$296,263
|
Multiple Sclerosis
|
2015
|
NIAID
|
5R01AI101378-03
|
|
DLL4 Regulation of T Cell Migration in EAE
|
KARPUS, WILLIAM
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
IL
|
$386,250
|
Multiple Sclerosis
|
2015
|
NIAID
|
5R21AI109122-02
|
|
Exploring the function of a novel, microbiota-regulated gene in T cells
|
ROUND, JUNE
|
UNIVERSITY OF UTAH
|
UT
|
$186,250
|
Multiple Sclerosis
|
2015
|
NINDS
|
5F31NS079091-03
|
|
Function of microglia in demyelination and remyelination
|
MARZAN, DAVE
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$43,120
|
Multiple Sclerosis
|
2015
|
NINDS
|
5P01NS076410-03
|
8634
|
Transcriptional regulations of effector and regulatory T cells in EAE
|
KUCHROO, VIJAY
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$252,100
|
Multiple Sclerosis
|
2015
|
NINDS
|
5P01NS076410-03
|
8635
|
A transcriptional network analysis of Tr1 cells
|
LITTMAN, DAN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$416,068
|
Multiple Sclerosis
|
2015
|
NINDS
|
5P01NS076410-03
|
8639
|
Molecular Analysis of Effector and Regulatory T cell Responses in MS
|
WEINER, HOWARD
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$252,094
|
Multiple Sclerosis
|
2015
|
NINDS
|
5P01NS076410-03
|
8643
|
Expression Profiling Core
|
KUCHROO, VIJAY
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$111,840
|
Multiple Sclerosis
|
2015
|
NINDS
|
5R21NS085246-02
|
|
High throughput screening and in vivo testing of drugs to enhance remyelination
|
TESAR, PAUL
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$396,250
|
Multiple Sclerosis
|
2015
|
NINDS
|
5R01NS041249-15
|
|
Chemokines and Viral-Induced Neurologic Disease
|
LANE, THOMAS
|
UNIVERSITY OF UTAH
|
UT
|
$242,457
|
Multiple Sclerosis
|
2015
|
NINDS
|
5F31NS081828-03
|
|
CD4+ T cell Affinities in Secondary Progressive Demyelinating Disease
|
KERSH, ANNA
|
EMORY UNIVERSITY
|
GA
|
$31,814
|
Multiple Sclerosis
|
2015
|
NINDS
|
5R01NS073743-05
|
|
Local Mitochondrial Fusion in Myelinated Axons In Vivo
|
CHIU, SHING
|
UNIVERSITY OF WISCONSIN-MADISON
|
WI
|
$321,449
|
Multiple Sclerosis
|
2015
|
NINDS
|
5R01NS081141-03
|
|
Stimulating oligodendrocyte progenitor cell differentiation and remyelination
|
TIWARI-WOODRUFF, SEEMA
|
UNIVERSITY OF CALIFORNIA RIVERSIDE
|
CA
|
$332,500
|
Multiple Sclerosis
|
2015
|
NIAID
|
5R21AI107238-02
|
|
Role of Commensal Microbiota in Stressor-Induced Immunomodulation
|
BAILEY, MICHAEL
|
OHIO STATE UNIVERSITY
|
OH
|
$88,689
|
Multiple Sclerosis
|
2015
|
NINDS
|
5R01NS077755-04
|
|
Does chronic Theiler's demyelination require viral persistence?
|
LIPTON, HOWARD
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
IL
|
$348,906
|
Multiple Sclerosis
|
2015
|
NIAID
|
2P01AI073748-06A1
|
8634
|
Tim-3 regulation of CNS autoimmune responses
|
HAFLER, DAVID
|
YALE UNIVERSITY
|
CT
|
$557,310
|
Multiple Sclerosis
|
2015
|
NINDS
|
5R01NS036592-17
|
|
Role of CD4 T cell response in MHV-induced demyelination
|
PERLMAN, STANLEY
|
UNIVERSITY OF IOWA
|
IA
|
$329,420
|
Multiple Sclerosis
|
2015
|
NINDS
|
5R01NS081687-03
|
|
Molecular mechanisms of Th17 plasticity in MS
|
ZIEGLER, STEVEN
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
WA
|
$382,156
|
Multiple Sclerosis
|
2015
|
NIAID
|
1R01AI114581-01
|
|
Metabolic programming in TH17 cell differentiation
|
WANG, RUONING
|
RESEARCH INST NATIONWIDE CHILDREN'S HOSP
|
OH
|
$186,875
|
Multiple Sclerosis
|
2015
|
NINDS
|
5R21NS084382-02
|
|
Fluorinated 4-Aminopyridines for Therapy and Diagnosis of Multiple Sclerosis
|
POPKO, BRIAN
|
UNIVERSITY OF CHICAGO
|
IL
|
$197,500
|
Multiple Sclerosis
|
2015
|
NINDS
|
5F31NS083354-03
|
|
Generation of gene-corrected oligodendrocyte progenitor cells for autologus treat
|
LAGER, ANGELA
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$43,120
|
Multiple Sclerosis
|
2015
|
NEI
|
5R01EY023240-02
|
|
Microstructural Characterization of the Optic Nerve in Optic Neuritis
|
SMITH, SETH
|
VANDERBILT UNIVERSITY
|
TN
|
$257,250
|
Multiple Sclerosis
|
2015
|
NIAID
|
5R01AI105887-02
|
|
Metabolic checkpoint in TH17 cell differentiation
|
CHI, HONGBO
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
TN
|
$437,500
|
Multiple Sclerosis
|
2015
|
NINDS
|
5R21NS084335-02
|
|
CaMKIIbeta: a regulator of CNS myelination
|
FUSS, BABETTE
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
VA
|
$228,750
|
Multiple Sclerosis
|
2015
|
NINDS
|
5R21NS087511-02
|
|
In vivo cellular imaging of myelin plasticity and regeneration in cortical gray m
|
GRUTZENDLER, JAIME
|
YALE UNIVERSITY
|
CT
|
$208,125
|
Multiple Sclerosis
|
2015
|
NINDS
|
5R01NS076693-03
|
|
Remyelination after traumatic brain injury
|
BERGOLD, PETER
|
SUNY DOWNSTATE MEDICAL CENTER
|
NY
|
$281,750
|
Multiple Sclerosis
|
2015
|
NINDS
|
5R21NS084201-02
|
|
Predictive biomarkers for EAE development
|
FORSTHUBER, THOMAS
|
UNIVERSITY OF TEXAS SAN ANTONIO
|
TX
|
$183,750
|
Multiple Sclerosis
|
2015
|
NINDS
|
5R21NS084303-02
|
|
Does microglial TNFR2 contribute to the protective role of membrane TNF in EAE?
|
BRAMBILLA, ROBERTA
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
FL
|
$191,875
|
Multiple Sclerosis
|
2015
|
NICHD
|
5P01HD009402-36
|
5695
|
Proj 2: TNF-a Signaling of Oligodendrocyte Injury and Activity-Department Myelin
|
KRAIG, RICHARD
|
UNIVERSITY OF CHICAGO
|
IL
|
$242,115
|
Multiple Sclerosis
|
2015
|
NINDS
|
5F31NS087801-02
|
|
Gpr56 is a regulator of glial cell development and myelination
|
DEGENOVA, SARAH
|
WASHINGTON UNIVERSITY
|
MO
|
$29,520
|
Multiple Sclerosis
|
2015
|
NINDS
|
5R21NS087273-02
|
|
Discovery and evaluation of novel therapy for Niemann-Pick type C targeting NPC1
|
SPIEGEL, SARAH
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
VA
|
$190,625
|
Multiple Sclerosis
|
2015
|
NIDDK
|
5K01DK090105-05
|
|
The role of Tim-1 in immune regulation and autoimmunity
|
XIAO, SHENG
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$159,435
|
Multiple Sclerosis
|
2015
|
NIAID
|
1R01AI110822-01A1
|
|
Regulation of Th17 Functions in Autoimmune CNS Inflammation
|
MCGEACHY, MANDY
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$127,073
|
Multiple Sclerosis
|
2015
|
NHLBI
|
5F30HL108451-05
|
|
N-glycosylation as a downstream effector of Interleukin-7
|
MKHIKIAN, HAIK
|
UNIVERSITY OF CALIFORNIA-IRVINE
|
CA
|
$48,120
|
Multiple Sclerosis
|
2015
|
NINDS
|
5R01NS087539-02
|
|
Role of CD4 T cells in fatal alphavisus encephalomyelitis
|
GRIFFIN, DIANE
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$354,375
|
Multiple Sclerosis
|
2015
|
NIDCD
|
5R01DC013157-02
|
|
Synaptic mechanisms underlying auditory function and dysfunction
|
KIM, JUN HEE
|
UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
|
TX
|
$312,011
|
Multiple Sclerosis
|
2015
|
NINDS
|
5R01NS073633-05
|
|
Vitamin D, Epstein-Barr virus infection, and cigarette smoking and risk of multip
|
ASCHERIO, ALBERTO
|
HARVARD SCHOOL OF PUBLIC HEALTH
|
MA
|
$308,960
|
Multiple Sclerosis
|
2015
|
NCCAM
|
1K23AT008211-01A1
|
|
Mindfulness-based Stress Reduction for Multiple Sclerosis: Feasibility, Durability, and Clinical Outcomes
|
SENDERS, ANGELA
|
NATIONAL COLLEGE OF NATURAL MEDICINE
|
OR
|
$134,510
|
Multiple Sclerosis
|
2015
|
NINDS
|
5R01NS057194-07
|
|
Regulation of Autoimmune Encephalomyelitis
|
ZAGHOUANI, HABIB
|
UNIVERSITY OF MISSOURI-COLUMBIA
|
MO
|
$325,556
|
Multiple Sclerosis
|
2015
|
NINDS
|
5R01NS073810-04
|
|
Function of SHP-1 in oligodendrocytes
|
MASSA, PAUL
|
UPSTATE MEDICAL UNIVERSITY
|
NY
|
$279,125
|
Multiple Sclerosis
|
2015
|
NICHD
|
1K25HD079505-01A1
|
|
Advanced neuroimaging in pediatric spinal cord injury
|
BARAKAT, NADIA
|
CHILDREN'S HOSPITAL CORPORATION
|
MA
|
$131,693
|
Multiple Sclerosis
|
2015
|
NIAID
|
1R21AI111045-01A1
|
|
Mechanism of MALT1 Regulation by a Novel Ubiquitin Ligase
|
LI, HONGMIN
|
WADSWORTH CENTER
|
NY
|
$227,431
|
Multiple Sclerosis
|
2015
|
NIAID
|
1R21AI103701-01A1
|
|
Genetically modified HSC-HPC for management of aggressive demyelinating diseases
|
STROMINGER, JACK
|
HARVARD UNIVERSITY
|
MA
|
$211,250
|
Multiple Sclerosis
|
2015
|
NIAID
|
5R01AI105836-02
|
|
Novel RORgamma antagonists for inflammation and autoimmune disease
|
PIEDRAFITA, FRANCISCO
|
TORREY PINES INST FOR MOLECULAR STUDIES
|
FL
|
$580,731
|
Multiple Sclerosis
|
2015
|
NINDS
|
5R21NS087465-02
|
|
In Vivo Macromolecular and Protein-Based MRI in the Spinal Cord of MS Patients
|
SMITH, SETH
|
VANDERBILT UNIVERSITY
|
TN
|
$235,500
|
Multiple Sclerosis
|
2015
|
NIAID
|
5R01AI093531-05
|
|
Mechanism of Bach1-Mediated Transcriptional Regulation and Immune Function
|
BALTIMORE, DAVID
|
CALIFORNIA INSTITUTE OF TECHNOLOGY
|
CA
|
$405,000
|
Multiple Sclerosis
|
2015
|
NINDS
|
5K23NS078044-04
|
|
Disconnection as a model for cognitive dysfunction in multiple sclerosis
|
KLAWITER, ERIC
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$193,536
|
Multiple Sclerosis
|
2015
|
NINDS
|
5P01NS059560-07
|
5149
|
Validating diffusion MRI biomarkers of inflammation and axon pathologies in EAE
|
SONG, SHENG-KWEI
|
WASHINGTON UNIVERSITY
|
MO
|
$205,250
|
Multiple Sclerosis
|
2015
|
NINDS
|
5P01NS059560-07
|
5150
|
Targeting the BBB to treat CNS inflammation
|
KLEIN, ROBYN
|
WASHINGTON UNIVERSITY
|
MO
|
$283,078
|
Multiple Sclerosis
|
2015
|
NINDS
|
5P01NS059560-07
|
5151
|
BIOMARKERS AND PATHOGENESIS OF MS: FROM MOUSE TO HUMAN
|
CROSS, DOROTHY
|
WASHINGTON UNIVERSITY
|
MO
|
$331,369
|
Multiple Sclerosis
|
2015
|
NINDS
|
5P01NS059560-07
|
5153
|
Animal Models, Histology and Tissue Bank Core
|
KLEIN, ROBYN
|
WASHINGTON UNIVERSITY
|
MO
|
$137,193
|
Multiple Sclerosis
|
2015
|
NINDS
|
5P01NS059560-07
|
5154
|
Image Data Acquisition, Analysis, and Modeling Core
|
SONG, SHENG-KWEI
|
WASHINGTON UNIVERSITY
|
MO
|
$204,258
|
Multiple Sclerosis
|
2015
|
NIAID
|
5R03AI111592-02
|
|
The Role of IL-11 in Development of Th17-mediated Autoimmune Response in EAE
|
MARKOVIC-PLESE, SILVA
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$76,000
|
Multiple Sclerosis
|
2015
|
NINDS
|
5R01NS071996-05
|
|
Molecular and Cellular Mechanisms of IL-17 Signaling
|
LI, XIAOXIA
|
CLEVELAND CLINIC LERNER COM-CWRU
|
OH
|
$385,970
|
Multiple Sclerosis
|
2015
|
NIAID
|
5R01AI092106-06
|
|
CNS-Specific Regulatory CD8+ T Cells in Autoimmune Demyelination
|
KARANDIKAR, NITIN
|
UNIVERSITY OF IOWA
|
IA
|
$339,750
|
Multiple Sclerosis
|
2015
|
NIAID
|
5R01AI104519-03
|
|
Signaling functions of Peli family of E3 ubiquitin ligases
|
SUN, SHAO-CONG
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
TX
|
$400,000
|
Multiple Sclerosis
|
2015
|
NICHD
|
5K23HD069494-04
|
|
Unemployment in Multiple Sclerosis : The Role of Personality, Coping and Health
|
STROBER, LAUREN
|
KESSLER FOUNDATION, INC.
|
NJ
|
$110,755
|
Multiple Sclerosis
|
2015
|
NINDS
|
5R01NS060910-07
|
|
Statistical Methods for Multilevel Multivariate Functional Studies
|
CRAINICEANU, CIPRIAN
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$354,303
|
Multiple Sclerosis
|
2015
|
NIGMS
|
5SC1NS000001-03
|
|
Regulation of myelination by myosin II-mediated mechanotransduction
|
MELENDEZ-VASQUEZ, CARMEN
|
HUNTER COLLEGE
|
NY
|
$344,250
|
Multiple Sclerosis
|
2015
|
NIEHS
|
5R01ES017080-05
|
|
Novel Strategies to Identify GxE Contributions to MS Pathogenesis
|
BARCELLOS, LISA
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
CA
|
$572,704
|
Multiple Sclerosis
|
2015
|
NIAID
|
5R01AI099216-03
|
|
Autoimmune Encephalomyelitis And Regulatory T Cells
|
CHEN, YOUHAI
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$400,000
|
Multiple Sclerosis
|
2015
|
NINDS
|
7K23NS072366-03
|
|
Grey Matter of Lesions and Neurodegeration in Multiple Sclerosis on 7-Telsa MRI
|
HARRISON, DANIEL
|
UNIVERSITY OF MARYLAND BALTIMORE
|
MD
|
$180,711
|
Multiple Sclerosis
|
2015
|
NIAID
|
1R01AI113118-01A1
|
|
UNDERSTANDING AUTOREACTIVE T CELL PATHOGENICITY
|
EDELSON, BRIAN
|
WASHINGTON UNIVERSITY
|
MO
|
$381,250
|
Multiple Sclerosis
|
2015
|
NIGMS
|
5R01GM063074-12
|
|
Molecular Organization and Function of Paranodal Axo-Glial Junctions
|
BHAT, MANZOOR
|
UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
|
TX
|
$331,848
|
Multiple Sclerosis
|
2015
|
NIBIB
|
5K99EB016689-02
|
|
Functional Imaging and Resting State Connectivity in Human Spinal Cord at 7 Tesla
|
BARRY, ROBERT
|
VANDERBILT UNIVERSITY
|
TN
|
$88,830
|
Multiple Sclerosis
|
2015
|
NIAID
|
1R01AI110113-01A1
|
|
2D affinity and frequency of antigen specific Tregs
|
EVAVOLD, BRIAN
|
EMORY UNIVERSITY
|
GA
|
$387,900
|
Multiple Sclerosis
|
2015
|
NINDS
|
5R01NS036866-41
|
|
Glycosphingolipid Metabolism and Mental Retardation
|
DAWSON, GLYN
|
UNIVERSITY OF CHICAGO
|
IL
|
$341,250
|
Multiple Sclerosis
|
2015
|
NIAID
|
5R01AI098007-04
|
|
VISTA, a novel regulator of immunity and autoimmunity
|
NOELLE, RANDOLPH
|
DARTMOUTH COLLEGE
|
NH
|
$578,486
|
Multiple Sclerosis
|
2015
|
NINDS
|
5R01NS082347-03
|
|
Imaging neurodegeneration in multiple sclerosis
|
CALABRESI, PETER
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$442,785
|
Multiple Sclerosis
|
2015
|
NINDS
|
5R01NS075243-05
|
|
Chromatin Remodeling Control of CNS Myelination and Remyelination
|
LU, QING
|
CINCINNATI CHILDRENS HOSP MED CTR
|
OH
|
$341,250
|
Multiple Sclerosis
|
2015
|
NIAID
|
5UM1AI110557-02
|
|
University of Michigan Autoimmunity Center of Excellence, Clinical Research Progr
|
FOX, DAVID
|
UNIVERSITY OF MICHIGAN
|
MI
|
$77,542
|
Multiple Sclerosis
|
2015
|
NICHD
|
5R03HD079508-02
|
|
Neuromuscular Electrical Stimulation and Mobility in Multiple Sclerosis
|
ENOKA, ROGER
|
UNIVERSITY OF COLORADO
|
CO
|
$74,766
|
Multiple Sclerosis
|
2015
|
NINR
|
5F31NR014601-02
|
|
Effects of Physical Activity on Cognition in Persons with Multiple Sclerosis
|
MORRISON, JANET
|
UNIVERSITY OF TEXAS, AUSTIN
|
TX
|
$34,097
|
Multiple Sclerosis
|
2015
|
NINDS
|
5R21NS088411-02
|
|
The role of astrocytes in myelin maintenance and regeneration
|
GRUTZENDLER, JAIME
|
YALE UNIVERSITY
|
CT
|
$208,125
|
Multiple Sclerosis
|
2015
|
NINDS
|
5K08NS078555-03
|
|
immunopathogenesis of NMO-IgG and AQP4-specific T cells in neuromyelitis optica
|
LEVY, MICHAEL
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$193,023
|
Multiple Sclerosis
|
2015
|
NINDS
|
5K08NS079493-04
|
|
Leveraging genetics and environment to predict presymptomatic multiple sclerosis
|
XIA, ZONGQI
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$193,536
|
Multiple Sclerosis
|
2015
|
NINDS
|
5R01NS082102-03
|
|
Virus Infection Leads to Autoreactive T Cells Having Multiple TCRs
|
FUJINAMI, ROBERT
|
UNIVERSITY OF UTAH
|
UT
|
$325,938
|
Multiple Sclerosis
|
2015
|
NIAID
|
5R01AI113903-02
|
|
Functions of Hopx in immune tolerance in a model of Multiple Sclerosis
|
HAWIGER, DANIEL
|
SAINT LOUIS UNIVERSITY
|
MO
|
$376,607
|
Multiple Sclerosis
|
2015
|
NINDS
|
5R01NS073712-05
|
|
New Peptides for the Treatment of Multiple Sclerosis
|
BEETON, CHRISTINE
|
BAYLOR COLLEGE OF MEDICINE
|
TX
|
$359,159
|
Multiple Sclerosis
|
2015
|
NIAID
|
5R01AI046643-16
|
|
Immunomodulation of transplant rejection by Anti-CD3 mAb
|
BLUESTONE, JEFFREY
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
CA
|
$347,625
|
Multiple Sclerosis
|
2015
|
NINDS
|
5R01NS081237-03
|
|
Modulating B and T cell functions in EAE through gamma secretase and Notch
|
EAGAR, TODD
|
METHODIST HOSPITAL RESEARCH INSTITUTE
|
TX
|
$275,625
|
Multiple Sclerosis
|
2015
|
NINDS
|
5R01NS078041-03
|
|
Modulation of oligodendrocyte development by voltage-operated calcium channels.
|
PAEZ, PABLO
|
STATE UNIVERSITY OF NEW YORK AT BUFFALO
|
NY
|
$411,344
|
Multiple Sclerosis
|
2015
|
NIAID
|
5R01AI050059-11
|
|
Autoimmune encephalomyelitis and c-Rel
|
CHEN, YOUHAI
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$400,000
|
Multiple Sclerosis
|
2015
|
NIAMS
|
5R01AR048632-14
|
|
CD1 presentation of self glycolipids and lipopeptides to T cells
|
MOODY, DAVID
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$368,420
|
Multiple Sclerosis
|
2015
|
NINDS
|
5R01NS076573-04
|
|
Efficient Targeting of Therapeutic Cells in Stroke and EAE
|
WALCZAK, PIOTR
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$354,375
|
Multiple Sclerosis
|
2015
|
NINDS
|
5K23NS069806-04
|
|
Development of visual and neurologic outcome measures in pediatric MS
|
WALDMAN, AMY
|
CHILDREN'S HOSP OF PHILADELPHIA
|
PA
|
$186,025
|
Multiple Sclerosis
|
2015
|
NINDS
|
5R01NS083678-03
|
|
ROLE OF B CELL ANTIGEN PRESENTATION IN AUTOIMMUNE ENCEPHALOMYELITIS
|
WU, GREGORY
|
WASHINGTON UNIVERSITY
|
MO
|
$332,500
|
Multiple Sclerosis
|
2015
|
NIAID
|
5R01AI107759-03
|
|
Molecular Regulation of MS Susceptibility Genes
|
WEAVER, CASEY
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$367,500
|
Multiple Sclerosis
|
2015
|
NINDS
|
5R01NS071463-05
|
|
Environmental and genetic risk factors for pediatric MS
|
WAUBANT, EMMANUELLE
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
CA
|
$501,864
|
Multiple Sclerosis
|
2015
|
NINDS
|
5R01NS073425-05
|
|
Inflammation and NG2 Cell Differentiation
|
NISHIYAMA, AKIKO
|
UNIVERSITY OF CONNECTICUT STORRS
|
CT
|
$327,262
|
Multiple Sclerosis
|
2015
|
NINDS
|
5R01NS075260-04
|
|
NSCs produce a triply effective cocktail in the CNS for MS/EAE therapy
|
ZHANG, GUANG-XIAN
|
THOMAS JEFFERSON UNIVERSITY
|
PA
|
$305,156
|
Multiple Sclerosis
|
2015
|
NCCAM
|
5R01AT007452-02
|
|
Mechanisms of human immune modulation by oral N-acetylglucosamine
|
DEMETRIOU, MICHAEL
|
UNIVERSITY OF CALIFORNIA-IRVINE
|
CA
|
$396,477
|
Multiple Sclerosis
|
2015
|
NEI
|
5R01EY013574-13
|
|
Aquaporin-4 in NMO Optic Neuritis: Pathogenesis and New Therapies
|
VERKMAN, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
CA
|
$388,119
|
Multiple Sclerosis
|
2015
|
NINDS
|
5R01NS026543-26
|
|
Immunoregulation and Pathology of Chronic-Relapsing EAE
|
MILLER, STEPHEN
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
IL
|
$337,969
|
Multiple Sclerosis
|
2015
|
NINDS
|
5R01NS078244-04
|
|
Lesion Activity and Atrophy in Multiple Sclerosis: Analysis of Multi-center MRI
|
NARAYANA, PONNADA
|
UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
|
TX
|
$332,500
|
Multiple Sclerosis
|
2015
|
NINDS
|
5R01NS080890-03
|
|
Estrogen-Induced Regulatory B Cells Protect Against EAE & Limit CNS Inflammation
|
OFFNER, HALINA
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
OR
|
$336,875
|
Multiple Sclerosis
|
2015
|
NINDS
|
5R01NS082257-03
|
|
Investigating the mechanism of TNFalpha mediated cell death in oligodendrocytes
|
YUAN, JUNYING
|
HARVARD MEDICAL SCHOOL
|
MA
|
$370,781
|
Multiple Sclerosis
|
2015
|
NINDS
|
5R01NS076588-04
|
|
Brain Oxygen Metabolism and Hemodynamic Impairment in Multiple Sclerosis
|
GE, YULIN
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$538,305
|
Multiple Sclerosis
|
2015
|
NCCAM
|
5R01AT006681-05
|
|
Cinnamon, CNTF and EAE
|
PAHAN, KALIPADA
|
RUSH UNIVERSITY MEDICAL CENTER
|
IL
|
$363,750
|
Multiple Sclerosis
|
2015
|
NIAID
|
5R37AI107494-03
|
|
Mechanisms by which CD8 T cells shape CNS autoimmunity initiated by CD4 T cells
|
GOVERMAN, JOAN
|
UNIVERSITY OF WASHINGTON
|
WA
|
$481,876
|
Multiple Sclerosis
|
2015
|
NINDS
|
5R01NS088367-02
|
|
A Mouse Model to Define Immunovirologic Determinants of Polyomavirus CNS Disease
|
LUKACHER, ARON
|
PENNSYLVANIA STATE UNIV HERSHEY MED CTR
|
PA
|
$334,688
|
Multiple Sclerosis
|
2015
|
NIAID
|
5R01AI103347-03
|
|
Engineering DNA nanoparticles to create immune tolerance
|
MELLOR, ANDREW
|
GEORGIA REGENTS UNIVERSITY
|
GA
|
$375,000
|
Multiple Sclerosis
|
2015
|
NIAID
|
1P01AI108545-01A1
|
5975
|
Modulation of Tolerance and Autoimmunity by Inhibitory Receptors
|
SHARPE, ARLENE
|
HARVARD MEDICAL SCHOOL
|
MA
|
$587,031
|
Multiple Sclerosis
|
2015
|
NIAID
|
5R21AI109150-02
|
|
Screening of Combinatorial Libraries for Complement C5 Inhibitors
|
SCHRAUFSTATTER, INGRID
|
TORREY PINES INST FOR MOLECULAR STUDIES
|
FL
|
$273,000
|
Multiple Sclerosis
|
2015
|
NINR
|
5R01NR014362-03
|
|
A Multi-Site Trial of a Cognitive Rehabilitation Intervention for Persons with MS
|
STUIFBERGEN, ALEXA
|
UNIVERSITY OF TEXAS, AUSTIN
|
TX
|
$435,325
|
Multiple Sclerosis
|
2015
|
NINDS
|
1R01NS091084-01
|
|
The role of ERK1/2 MAP kinase signaling in CNS myelination
|
FYFFE-MARICICH, SHARYL
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$332,150
|
Multiple Sclerosis
|
2015
|
NIAID
|
5R01AI043496-14
|
|
Immune Regulation of Neural Stem Cell Program in EAE
|
KHOURY, SAMIA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$393,263
|
Multiple Sclerosis
|
2015
|
NIAID
|
5R01AI079056-07
|
|
The roles of Sirt1, a deacetylase, in immune tolerance and autoimmunity
|
FANG, DEYU
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
IL
|
$386,250
|
Multiple Sclerosis
|
2015
|
NIAID
|
5U01AI101990-04
|
|
Defining the role of altered cytokine signaling pathways on autoimmunity
|
BUCKNER, JANE
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
WA
|
$2,279,030
|
Multiple Sclerosis
|
2015
|
Type 1 Diabetes
|
5U01AI101990-04
|
|
Defining the role of altered cytokine signaling pathways on autoimmunity
|
BUCKNER, JANE
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
WA
|
$171,754
|
Multiple Sclerosis
|
2015
|
NINDS
|
5R37NS042925-13
|
|
Histone Deacetylation in Oligodendrocyte Differentiation
|
CASACCIA, PATRIZIA
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
NY
|
$578,179
|
Multiple Sclerosis
|
2015
|
NINDS
|
1R21NS091890-01
|
|
Anti-inflammatory (M2) macrophage signaling in CNS remyelination
|
HUANG, JEFFREY
|
GEORGETOWN UNIVERSITY
|
DC
|
$233,250
|
Multiple Sclerosis
|
2015
|
NINDS
|
5R01NS086299-03
|
|
Regulation of B cells in the CNS
|
BERGMANN, CORNELIA
|
CLEVELAND CLINIC LERNER COM-CWRU
|
OH
|
$346,719
|
Multiple Sclerosis
|
2015
|
NIBIB
|
1K99EB020075-01
|
|
New tools for imaging: diagnostics based on therapeutics
|
BRUGAROLAS, PEDRO
|
UNIVERSITY OF CHICAGO
|
IL
|
$83,718
|
Multiple Sclerosis
|
2015
|
NINDS
|
1R03NS091753-01
|
|
Neuronal Activity and Vascular Coupling in fMRI Studies of Multiple Sclerosis
|
LOWE, MARK
|
CLEVELAND CLINIC LERNER COM-CWRU
|
OH
|
$73,108
|
Multiple Sclerosis
|
2015
|
NINDS
|
5R01NS076993-04
|
|
DISSECTING NEURAL CELL FATE SPECIFICATION USING TRANSPOSON CALLING CARDS
|
MITRA, ROBI
|
WASHINGTON UNIVERSITY
|
MO
|
$332,500
|
Multiple Sclerosis
|
2015
|
NIEHS
|
1R21ES025304-01
|
|
Pollution Aggravates Autoimmunity Through the Aryl Hydrocarbon Receptor
|
MEZRICH, JOSHUA
|
UNIVERSITY OF WISCONSIN-MADISON
|
WI
|
$229,500
|
Multiple Sclerosis
|
2015
|
NIAID
|
5U01AI102011-04
|
|
The role of the innate immune system on Treg reprogramming in human autoimmune di
|
HAFLER, DAVID
|
YALE UNIVERSITY
|
CT
|
$380,599
|
Multiple Sclerosis
|
2015
|
Type 1 Diabetes
|
5U01AI102011-04
|
|
The role of the innate immune system on Treg reprogramming in human autoimmune di
|
HAFLER, DAVID
|
YALE UNIVERSITY
|
CT
|
$361,806
|
Multiple Sclerosis
|
2015
|
NINDS
|
1R01NS092042-01
|
|
Human neural precursor cell-mediated therapy in a viral model of demyelination
|
LANE, THOMAS
|
UNIVERSITY OF UTAH
|
UT
|
$570,252
|
Multiple Sclerosis
|
2015
|
NIAID
|
5R01AI103629-03
|
|
A longitudinal immunological and virological study for ME CFS biomarker discovery
|
NACUL, LUIS
|
LONDON SCH/HYGIENE & TROPICAL MEDICINE
|
UK
|
$613,400
|
Multiple Sclerosis
|
2015
|
NINDS
|
5R37NS038878-17
|
|
Role of FGF-Signaling in Myelinogenesis
|
BANSAL, RASHMI
|
UNIVERSITY OF CONNECTICUT SCH OF MED/DNT
|
CT
|
$385,000
|
Multiple Sclerosis
|
2015
|
NINDS
|
5U01NS082329-03
|
|
Ibudilast Phase II trial in progressive MS
|
FOX, ROBERT
|
CLEVELAND CLINIC LERNER COM-CWRU
|
OH
|
$2,827,318
|
Multiple Sclerosis
|
2015
|
NIMH
|
5R01MH098742-04
|
|
Oligodendrocyte damage and dysfunction in HIV associated neurocognitive disorder
|
JORDANSCIUTTO, KELLY
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$532,571
|
Multiple Sclerosis
|
2015
|
NINDS
|
5R01NS080976-03
|
|
Hippocampal Demyelination and Cognitive Dysfunction
|
TRAPP, BRUCE
|
CLEVELAND CLINIC LERNER COM-CWRU
|
OH
|
$346,719
|
Multiple Sclerosis
|
2015
|
NINDS
|
5F31NS081903-03
|
|
C-reactive Protein, Autoimmunity, and Inflammation in the Central Nervous System
|
WRIGHT, TYLER
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$11,909
|
Multiple Sclerosis
|
2015
|
NINDS
|
5R01NS072150-05
|
|
Interferons as adjuvants for tolerogenic vaccines
|
MANNIE, MARK
|
EAST CAROLINA UNIVERSITY
|
NC
|
$311,773
|
Multiple Sclerosis
|
2015
|
NINR
|
5R03NR014515-02
|
|
Characteristics of Symptoms and Functioning in Multiple Sclerosis
|
KRATZ, ANNA
|
UNIVERSITY OF MICHIGAN
|
MI
|
$46,136
|
Multiple Sclerosis
|
2015
|
NINDS
|
5R01NS069690-05
|
|
Viral suppression of CNS autoimmunity
|
STOHLMAN, STEPHEN
|
CLEVELAND CLINIC LERNER COM-CWRU
|
OH
|
$343,438
|
Multiple Sclerosis
|
2015
|
NIAID
|
1R01AI113007-01A1
|
|
STAT4 regulation of effector CD4 T cells and CNS inflammation
|
HARRINGTON, LAURIE
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$367,500
|
Multiple Sclerosis
|
2015
|
NINDS
|
5R01NS052189-12
|
|
Mechanisms of Fibrin Action in Multiple Sclerosis
|
AKASSOGLOU, KATERINA
|
J. DAVID GLADSTONE INSTITUTES
|
CA
|
$587,244
|
Multiple Sclerosis
|
2015
|
NINDS
|
5R01NS074987-06
|
|
Viral-induced demyelination and neural stem cell-mediated remyelination
|
LANE, THOMAS
|
UNIVERSITY OF UTAH
|
UT
|
$309,838
|
Multiple Sclerosis
|
2015
|
NINDS
|
5R01NS075345-05
|
|
Molecular Regulation of Human Glial Progenitor Cell-Based Remyelination
|
GOLDMAN, STEVEN
|
UNIVERSITY OF ROCHESTER
|
NY
|
$337,969
|
Multiple Sclerosis
|
2015
|
NIBIB
|
2R01EB013198-06
|
|
Antigen loaded particles for tolerance induction
|
SHEA, LONNIE
|
UNIVERSITY OF MICHIGAN
|
MI
|
$563,493
|
Multiple Sclerosis
|
2015
|
NIAID
|
5R01AI106923-02
|
|
The Role of microRNAs in autoimmune disease
|
JEKER, LUKAS
|
UNIVERSITY HOSPITAL BASEL
|
SWITZE
|
$262,495
|
Multiple Sclerosis
|
2015
|
NICHD
|
5R01HD080601-02
|
|
Chemical and Genetic Screens for Modulators of Nervous System Development
|
MONK, KELLY
|
WASHINGTON UNIVERSITY
|
MO
|
$307,514
|
Multiple Sclerosis
|
2015
|
NINDS
|
1R01NS083542-01A1
|
|
Role of LRP1 in NF-kB mediated neuroinflammation
|
GAULTIER, ALBAN
|
UNIVERSITY OF VIRGINIA
|
VA
|
$340,310
|
Multiple Sclerosis
|
2015
|
NINDS
|
2R01NS072427-07
|
|
Molecular Mechanisms of Oligodendrocyte Differentiation and Myelination
|
LU, QING
|
CINCINNATI CHILDRENS HOSP MED CTR
|
OH
|
$466,702
|
Multiple Sclerosis
|
2015
|
NINDS
|
1R01NS088437-01A1
|
|
Small molecule in vivo probe development targeting the IL-6/STAT3 pathway for potential multiple sclerosis therapy
|
LI, CHENGLONG
|
OHIO STATE UNIVERSITY
|
OH
|
$471,114
|
Multiple Sclerosis
|
2015
|
NINDS
|
1R01NS086981-01A1
|
|
Bringing CLARITY to EAE
|
MACKENZIE-GRAHAM, ALLAN
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$336,875
|
Multiple Sclerosis
|
2015
|
NIAID
|
1R01AI110586-01A1
|
|
Commensal Exopolysaccharide Protection from Inflammation
|
KNIGHT, KATHERINE
|
LOYOLA UNIVERSITY CHICAGO
|
IL
|
$200,635
|
Multiple Sclerosis
|
2015
|
NEI
|
5R01EY024655-02
|
|
3D segmentation and registration of macular SD-OCT for application in MS
|
PRINCE, JERRY
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$382,576
|
Multiple Sclerosis
|
2015
|
NIAID
|
5R01AI108634-02
|
|
The roles of Synoviolin in immune tolerance and autoimmunity
|
FANG, DEYU
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
IL
|
$379,464
|
Multiple Sclerosis
|
2015
|
NHLBI
|
5K08HL105672-05
|
|
Mechanisms Linking Hemostatic Facotrs to Neuroinflammatory Disease
|
MULLINS, ERIC
|
CINCINNATI CHILDRENS HOSP MED CTR
|
OH
|
$131,085
|
Multiple Sclerosis
|
2015
|
NIDDK
|
1R01DK105550-01
|
|
Exploiting metabolic vulnerabilities of CD4 T cell subsets to control inflammatory disease
|
RATHMELL, JEFFREY
|
DUKE UNIVERSITY
|
NC
|
$393,554
|
Multiple Sclerosis
|
2015
|
NIAID
|
5R21AI107748-02
|
|
Role of TGFBR3 in T-cell development and immune response
|
RAMAN, CHANDER
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$183,750
|
Multiple Sclerosis
|
2015
|
NHLBI
|
5R37HL057506-19
|
|
Inflammation in Vascular Injury and Repair
|
SIMON, DANIEL
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$416,503
|
Multiple Sclerosis
|
2015
|
NIAID
|
1R21AI113220-01A1
|
|
The REL gene and human autoimmune diseases
|
CHEN, YOUHAI
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$240,000
|
Multiple Sclerosis
|
2015
|
NINDS
|
1K23NS087151-01A1
|
|
The effect of vitamin D3 on markers of oxidative stress in boys with X-linked ALD
|
VAN HAREN, KEITH
|
STANFORD UNIVERSITY
|
CA
|
$186,305
|
Multiple Sclerosis
|
2015
|
NINDS
|
5R01NS075308-05
|
|
Vitamin D, Race/Ethnicity, Genotype, and Multiple Sclerosis
|
LANGER-GOULD, ANNETTE
|
KAISER FOUNDATION RESEARCH INSTITUTE
|
CA
|
$600,495
|
Multiple Sclerosis
|
2015
|
NINDS
|
1R21NS087578-01A1
|
|
Proteomic and Functional Analyses of Astrocyte Exosomes
|
CROCKER, STEPHEN
|
UNIVERSITY OF CONNECTICUT SCH OF MED/DNT
|
CT
|
$230,988
|
Multiple Sclerosis
|
2015
|
NIBIB
|
1R21EB019166-01A1
|
|
Multifunctional Biomaterial for Amelioration of MS in Murine EAE Model
|
BABENSEE, JULIA
|
GEORGIA INSTITUTE OF TECHNOLOGY
|
GA
|
$210,157
|
Multiple Sclerosis
|
2015
|
NINDS
|
5R01NS081281-04
|
|
Neuronal regulation of myelination
|
GIGER, ROMAN
|
UNIVERSITY OF MICHIGAN
|
MI
|
$334,296
|
Multiple Sclerosis
|
2015
|
NINDS
|
5R01NS082203-04
|
|
The role of mTOR signaling in oligodendrocyte differentiation and CNS myelination
|
MACKLIN, WENDY
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$698,470
|
Multiple Sclerosis
|
2015
|
NIAID
|
5R01AI106026-10
|
|
The role of IL-27 in iv tolerance in EAE
|
ROSTAMI, A.M.
|
THOMAS JEFFERSON UNIVERSITY
|
PA
|
$387,500
|
Multiple Sclerosis
|
2015
|
NIAID
|
5R21AI109690-02
|
|
Novel biochemical and functional targets of PARP
|
BOOTHBY, MARK
|
VANDERBILT UNIVERSITY
|
TN
|
$196,216
|
Multiple Sclerosis
|
2015
|
NIAID
|
7R01AI101982-03
|
|
Modulation of Inflammatory Responses by Helminth Glycans
|
CUMMINGS, RICHARD
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
MA
|
$514,349
|
Multiple Sclerosis
|
2015
|
NIEHS
|
5R01ES022966-02
|
|
AhR and Regulatory T cells
|
MCKARNS, SUSAN
|
UNIVERSITY OF MISSOURI-COLUMBIA
|
MO
|
$331,899
|
Multiple Sclerosis
|
2015
|
NIAID
|
5P01AI056299-12
|
5194
|
T Cell costimulation: Induction and Regulation of Autoimmunity
|
KUCHROO, VIJAY
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$552,187
|
Multiple Sclerosis
|
2015
|
NINDS
|
1R44NS092137-01
|
|
MLKi Therapy for Cognitive Impairment in Multiple Sclerosis
|
GOODFELLOW, VAL
|
CALIFIA BIO, INC.
|
CA
|
$586,679
|
Multiple Sclerosis
|
2015
|
NCCAM
|
5R01AT006888-05
|
|
Role of natural indoles in experimental autoimmune encephalomyelitis
|
NAGARKATTI, MITZI
|
UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA
|
SC
|
$386,789
|
Multiple Sclerosis
|
2015
|
NINDS
|
1R43NS090908-01A1
|
|
Development of Diagnostic Test for Early Multiple Sclerosis
|
SCHUTZER, STEVEN
|
BIOSCIENCE DEVELOPMENT, INC.
|
NY
|
$299,998
|
Multiple Sclerosis
|
2015
|
NIBIB
|
5UH3EB013647-05
|
|
Gravitational Regulation of Osteoblast Genomics and Metabolism
|
HAMMER, BRUCE
|
UNIVERSITY OF MINNESOTA
|
MN
|
$423,517
|
Multiple Sclerosis
|
2015
|
NINDS
|
5R01NS072141-05
|
|
The Role of Intrathecal Plasma Cell Clones in MS Pathogenesis
|
OWENS, GREGORY
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$267,750
|
Multiple Sclerosis
|
2015
|
NINDS
|
5R01NS085103-02
|
|
Kruppel-like factor-6 signaling in myelin formation and repair
|
JOHN, GARETH
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
NY
|
$370,781
|
Multiple Sclerosis
|
2015
|
NINDS
|
5R01NS090383-02
|
|
Role of Endothelin-1 in remyelination
|
GALLO, VITTORIO
|
CHILDREN'S RESEARCH INSTITUTE
|
DC
|
$376,250
|
Multiple Sclerosis
|
2015
|
NINDS
|
1F31NS089260-01A1
|
|
DCE-MRI assessment of cortical grey matter changes in multiple sclerosis
|
TAGGE, IAN
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
OR
|
$43,120
|
Multiple Sclerosis
|
2015
|
NINDS
|
1F32NS092448-01
|
|
Maintenance and Reorganization of Molecular Domains in Myelinated Axons
|
TAYLOR, ANNA
|
UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
|
TX
|
$52,406
|
Multiple Sclerosis
|
2015
|
NINDS
|
1R01NS090464-01A1
|
|
Multiple Sclerosis Lesion Magnetic Susceptibility Activity
|
WANG, YI
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
NY
|
$408,607
|
Multiple Sclerosis
|
2015
|
NINDS
|
5R01NS088729-02
|
|
The Role of GM-CSF in the Pathogenesis of Multiple Sclerosis
|
ROSTAMI, A.M.
|
THOMAS JEFFERSON UNIVERSITY
|
PA
|
$341,068
|
Multiple Sclerosis
|
2015
|
NIAID
|
5P01AI045757-17
|
6982
|
Ex vivo Analysis of Autoreactive T Cells from Patients with Multiple Sclerosis
|
LOVE, JOHN
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
MA
|
$318,649
|
Multiple Sclerosis
|
2015
|
NIAID
|
5P01AI045757-17
|
6983
|
Molecular Characterization of Myelin-Specific T cells from MS Patients
|
WUCHERPFENNIG, KAI
|
DANA-FARBER CANCER INST
|
MA
|
$436,155
|
Multiple Sclerosis
|
2015
|
NIAID
|
5P01AI045757-17
|
6984
|
T:B Collaboration and Induction of Autoimmune Tissue Inflammation
|
KUCHROO, VIJAY
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$310,608
|
Multiple Sclerosis
|
2015
|
NIAID
|
5P01AI045757-17
|
6985
|
Regulation of T cell immunity by stromal cells in autoimmune tissue inflammation
|
REGEV, AVIV
|
DANA-FARBER CANCER INST
|
MA
|
$310,263
|
Multiple Sclerosis
|
2015
|
NIAID
|
5P01AI045757-17
|
6986
|
Novel Technologies for Investigation of Self-reactive T cells in MS and Relevant
|
LOVE, JOHN
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
MA
|
$265,382
|
Multiple Sclerosis
|
2015
|
NINDS
|
1F31NS092371-01
|
|
The Effects of Voluntary Exercise on Oligodendroglia and Myelin in Developing and Cuprizone-Treated Mice.
|
TOMLINSON, LYL
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
NY
|
$36,696
|
Multiple Sclerosis
|
2015
|
NINDS
|
1R21NS090901-01A1
|
|
Glutamate transporters as regulators of CNS myelination
|
FUSS, BABETTE
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
VA
|
$190,625
|
Multiple Sclerosis
|
2015
|
NINDS
|
5R01NS045937-13
|
|
Role of Th1 specific cell surface molecule Tim-3 in EAE
|
KUCHROO, VIJAY
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$351,816
|
Multiple Sclerosis
|
2015
|
NINDS
|
5R01NS088040-02
|
|
Mesoscopic Biomarkers of Neurodegeneration with Diffusion MRI
|
NOVIKOV, DMITRY
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$370,781
|
Multiple Sclerosis
|
2015
|
NINDS
|
5R21NS085278-02
|
|
Lentivirus Transduced Tolerogenic Dendritic Cells For The Treatment Of CIDP
|
SAHENK, ZARIFE
|
RESEARCH INST NATIONWIDE CHILDREN'S HOSP
|
OH
|
$155,318
|
Multiple Sclerosis
|
2015
|
NINDS
|
5R01NS057563-07
|
|
Therapeutic Intervention of the JAK/STAT Pathway for Neuroinflammation
|
BENVENISTE, ETTY
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$321,563
|
Multiple Sclerosis
|
2015
|
NINDS
|
5R00NS075099-05
|
|
Molecular Stratification of Multiple Sclerosis and Associated Neuro-autoimmune Di
|
AXTELL, ROBERT
|
OKLAHOMA MEDICAL RESEARCH FOUNDATION
|
OK
|
$249,000
|
Multiple Sclerosis
|
2015
|
NINDS
|
5R01NS077942-05
|
|
Cdk5 regulates oligodendrocyte development, myelination and repair
|
YANG, YAN
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$343,438
|
Multiple Sclerosis
|
2015
|
NINDS
|
5F31NS081834-04
|
|
Signaling pathways regulating myelination in the CNS
|
AHRENDSEN, JARED
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$28,071
|
Multiple Sclerosis
|
2015
|
NINDS
|
5F31NS084691-03
|
|
C-kit Signaling Pathways Regulate EAE Susceptibility in Male SJL Mice
|
SHORT, ABIGAIL
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
IL
|
$48,120
|
Multiple Sclerosis
|
2015
|
NINDS
|
5R01NS078322-03
|
|
Cortical mechanisms of disease progression in early multiple sclerosis
|
MAINERO, CATERINA
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$380,625
|
Multiple Sclerosis
|
2015
|
NINDS
|
5R21NS087986-02
|
|
Disease Modifying Potential of Glatiramer Acetate in Huntington's disease
|
THOMAS, ELIZABETH
|
SCRIPPS RESEARCH INSTITUTE
|
CA
|
$236,875
|
Multiple Sclerosis
|
2015
|
NINDS
|
5R37NS041435-15
|
|
Mechanisms by which effector T cells modulate endogenous remyelination
|
CALABRESI, PETER
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$405,000
|
Multiple Sclerosis
|
2015
|
NINDS
|
5R01NS088155-02
|
|
Post GWAS approach to identify cell-specific genetic pathways underlying MS risk
|
BARANZINI, SERGIO
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
CA
|
$511,329
|
Multiple Sclerosis
|
2015
|
NCCAM
|
5P01AT003961-07
|
8452
|
Epigenetic pathways in resveratrol-induced amelioration of neuroinflammation
|
NAGARKATTI, PRAKASH
|
UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA
|
SC
|
$330,644
|
Multiple Sclerosis
|
2015
|
NEI
|
5K08EY023981-02
|
|
Optic neuritis in aquaporin-4-IgG seropositive neuromyelitis optica
|
LEVIN, MARC
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
CA
|
$224,852
|
Multiple Sclerosis
|
2015
|
NINDS
|
5F32NS090820-02
|
|
Cellular mechanisms of cortical myelin plasticity and regeneration in vivo
|
HILL, ROBERT
|
YALE UNIVERSITY
|
CT
|
$56,042
|
Multiple Sclerosis
|
2015
|
NIAMS
|
5K01AR065481-02
|
|
Inhibition of ZAP-70 to selectively attenuate autoimmune disease-inducing T cells
|
AU-YEUNG, BYRON
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
CA
|
$128,385
|
Multiple Sclerosis
|
2015
|
NINDS
|
5R01NS064599-07
|
|
The MKP-1/p38 axis: coordinating innate and adaptive immunity
|
CHI, HONGBO
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
TN
|
$382,813
|
Multiple Sclerosis
|
2015
|
NINDS
|
5R01NS088137-02
|
|
Mechanism of regulation of CNS inflammation by microglia
|
BUTOVSKY, OLEG
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$344,068
|
Multiple Sclerosis
|
2015
|
NINDS
|
5R21NS090910-02
|
|
NONINVASIVELY DISTINGUISHING INFLAMMATION FROM TISSUE INJURY IN OPTIC NEURITIS
|
NAISMITH, ROBERT
|
WASHINGTON UNIVERSITY
|
MO
|
$194,284
|
Multiple Sclerosis
|
2015
|
NINDS
|
5R01NS030800-19
|
|
development of oligodendrocytes in the spinal cord
|
MILLER, ROBERT
|
GEORGE WASHINGTON UNIVERSITY
|
DC
|
$346,719
|
Multiple Sclerosis
|
2015
|
NINDS
|
5R01NS079653-02
|
|
Susceptibility MRI as a marker for diagnosis and clinical disability in MS
|
LIU, CHUNLEI
|
DUKE UNIVERSITY
|
NC
|
$239,607
|
Multiple Sclerosis
|
2015
|
NINDS
|
5R01NS087226-02
|
|
Gut Microbiota in Patients with Multiple Sclerosis
|
WEINER, HOWARD
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$388,099
|
Multiple Sclerosis
|
2015
|
NINDS
|
5R21NS087474-02
|
|
Therapies to Stimulate Remyelination
|
BONGARZONE, ERNESTO
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
IL
|
$217,988
|
Multiple Sclerosis
|
2015
|
NINDS
|
1R01NS092650-01
|
|
UTE Magnetic Resonance Imaging: New Biomarkers for Multiple Sclerosis
|
DU, JIANG
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$354,043
|
Multiple Sclerosis
|
2015
|
NEI
|
1R01EY025687-01
|
|
Mechanisms of Activity-Dependent Myelination in the Visual System
|
DESILVA, TARA
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$367,500
|
Multiple Sclerosis
|
2015
|
NINDS
|
1R01NS093357-01
|
|
Human iPSC and glial chimeric modeling of Pelizaeus-Merzbacher Disease
|
TESAR, PAUL
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$389,819
|
Multiple Sclerosis
|
2015
|
NINDS
|
1R01NS092835-01
|
|
Disease relevance of CD20 expression on T cells in multiple sclerosis patients
|
VON BUEDINGEN, HANS-CHRISTIAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
CA
|
$366,525
|
Multiple Sclerosis
|
2015
|
NIAID
|
1R01AI119135-01
|
|
HuR regulates Th17 cells for promoting autoimmune neuroinflammation
|
YU, SHIGUANG
|
ARKANSAS STATE UNIVERSITY
|
AR
|
$340,000
|
Multiple Sclerosis
|
2015
|
NICHD
|
1DP1HD087988-01
|
|
SMOCs: Novel Signal Transduction Complexes as New Targets for Drug Discovery
|
WU, HAO
|
CHILDREN'S HOSPITAL CORPORATION
|
MA
|
$1
|
Multiple Sclerosis
|
2015
|
RMAP
|
1DP1HD087988-01
|
|
SMOCs: Novel Signal Transduction Complexes as New Targets for Drug Discovery
|
WU, HAO
|
CHILDREN'S HOSPITAL CORPORATION
|
MA
|
$885,000
|
Multiple Sclerosis
|
2015
|
NINDS
|
1R21NS093487-01
|
|
Role of Caspase-8 in Neuroinflammation, Demyelination and Myelin Repair
|
LI, JIANRONG
|
TEXAS A&M AGRILIFE RESEARCH
|
TX
|
$221,250
|
Multiple Sclerosis
|
2015
|
NIBIB
|
1R21EB021005-01
|
|
A High-Throughput Microfluidic in vitro CNS Myelination Model towards Drug Screening
|
HAN, ARUM
|
TEXAS ENGINEERING EXPERIMENT STATION
|
TX
|
$179,524
|
Multiple Sclerosis
|
2015
|
NINDS
|
7R01NS081141-02
|
|
Stimulating oligodendrocyte progenitor cell differentiation and remyelination
|
TIWARI-WOODRUFF, SEEMA
|
UNIVERSITY OF CALIFORNIA RIVERSIDE
|
CA
|
$315,420
|
Multiple Sclerosis
|
2015
|
NINDS
|
5F30NS090718-02
|
|
Role of Kruppel-like factor 6 in Oligodendrocyte Differentiation
|
LAITMAN, BENJAMIN
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
NY
|
$40,085
|
Multiple Sclerosis
|
2015
|
RMAP
|
4UH3TR000918-03
|
|
Exosome RNA-Therapeutics to Promote CNS Myelination
|
KRAIG, RICHARD
|
UNIVERSITY OF CHICAGO
|
IL
|
$322,669
|
Multiple Sclerosis
|
2015
|
RMAP
|
4UH3TR000890-03
|
|
Circulating MicroRNAs as Disease Biomarkers in Multiple Sclerosis
|
WEINER, HOWARD
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$321,545
|
Multiple Sclerosis
|
2015
|
NINDS
|
2R01NS062703-06
|
|
Reactive astrocytes control leukocyte and humoral trafficking into the CNS
|
JOHN, GARETH
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
NY
|
$370,781
|
Multiple Sclerosis
|
2015
|
NINDS
|
2R01NS030843-23
|
|
T cell response to myelin proteolipid protein
|
KUCHROO, VIJAY
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$366,058
|
Multiple Sclerosis
|
2015
|
NHLBI
|
2R01HL095722-06A1
|
|
Engineered Induction of a Stem Cell Homing Response
|
KARP, JEFFREY
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$443,645
|
Multiple Sclerosis
|
2015
|
NINDS
|
2R01NS037766-16A1
|
|
Cytokines in Glial Cells and EAE Brain
|
SINGH, INDERJIT
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
SC
|
$327,031
|
Multiple Sclerosis
|
2015
|
NIAID
|
2R42AI110170-02
|
|
Novel commensal polysaccharide treats multiple sclerosis through Treg modulation
|
KASPER, LLOYD
|
SYMBIOTIX BIOTHERAPIES, INC.
|
MA
|
$2,264,726
|
Multiple Sclerosis
|
2015
|
NINDS
|
1R43NS092182-01A1
|
|
RAP as a novel therapeutic to promote remyelination after MS demyelinating event
|
STILES, TRAVIS
|
NOVORON BIOSCIENCE, INC.
|
CA
|
$353,106
|
Multiple Sclerosis
|
2015
|
NINDS
|
1F31NS093935-01
|
|
The Role of ADAM10 in Central Nervous System Myelination and Remyelination
|
KLINGENER, MICHAEL
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
NY
|
$43,120
|
Multiple Sclerosis
|
2015
|
NICHD
|
1F30HD084167-01A1
|
|
Identifying molecular and cellular deficits in a human model of myelin disease
|
NEVIN, ZACHARY
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$40,105
|
Multiple Sclerosis
|
2015
|
NINDS
|
1F31NS093832-01
|
|
Direct and indirect effects of obesity genes on multiple sclerosis
|
GIANFRANCESCO, MILENA
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
CA
|
$36,896
|
Multiple Sclerosis
|
2015
|
NINDS
|
1R01NS094164-01
|
|
Adhesion G protein-coupled receptors in CNS development and regeneration
|
PIAO, XIANHUA
|
CHILDREN'S HOSPITAL CORPORATION
|
MA
|
$392,381
|
Multiple Sclerosis
|
2015
|
NIAID
|
272201200010C-10-0-4
|
|
IEDB for Multiple sclerosis, Rheumatoid Arthritis, Lupus, and Type 1 Diabetes
|
SETTE, ALESSANDRO
|
LA JOLLA INST FOR ALLERGY & IMMUNOLGY
|
CA
|
$186,228
|
Multiple Sclerosis
|
2015
|
NINDS
|
1R01NS094181-01
|
|
Transcription mechanism of Myrf for central nervous system myelination
|
PARK, YUNGKI
|
STATE UNIVERSITY OF NEW YORK AT BUFFALO
|
NY
|
$371,133
|
Multiple Sclerosis
|
2015
|
NCCAM
|
5F32AT008539-02
|
|
MicroRNA regulation of EAE by resveratrol
|
GANDY, K
|
UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA
|
SC
|
$60,542
|
Multiple Sclerosis
|
2015
|
NINDS
|
1R01NS094522-01
|
|
Molecular mechanisms of the protective function of oligodendroglial TNFR2: a new therapeutic target in neuro-immune disease
|
BRAMBILLA, ROBERTA
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
FL
|
$335,781
|
Multiple Sclerosis
|
2015
|
NINDS
|
1R56NS085201-01A1
|
|
Role of Adhesion G protein-coupled receptors in glial cell development and myelination
|
PIAO, XIANHUA
|
CHILDREN'S HOSPITAL CORPORATION
|
MA
|
$446,712
|
Multiple Sclerosis
|
2015
|
NINDS
|
1R01NS095280-01
|
|
Drug-mediated enhancement of myelination
|
TESAR, PAUL
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$405,069
|
Multiple Sclerosis
|
2015
|
NINDS
|
1R01NS091183-01A1
|
|
IL-10-dependent regulation of viral-induced demyelination
|
STOHLMAN, STEPHEN
|
CLEVELAND CLINIC LERNER COM-CWRU
|
OH
|
$364,188
|
Multiple Sclerosis
|
2015
|
NINDS
|
2R01NS026799-25A1
|
|
Gene linkage study of multiple sclerosis sibling pairs
|
HAUSER, STEPHEN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
CA
|
$424,978
|
Multiple Sclerosis
|
2015
|
NINDS
|
3R01NS083542-01A1S1
|
|
Role of LRP1 in NF-kB mediated neuroinflammation
|
GAULTIER, ALBAN
|
UNIVERSITY OF VIRGINIA
|
VA
|
$31,344
|
Multiple Sclerosis
|
2015
|
NICHD
|
1R03HD083727-01A1
|
|
Slope walking and spinal plasticity in people with multiple sclerosis
|
SABATIER, MANNING
|
EMORY UNIVERSITY
|
GA
|
$78,000
|
Multiple Sclerosis
|
2015
|
NINDS
|
1R01NS091683-01A1
|
|
Pathogenesis of Tissue Destruction in Multiple Sclerosis
|
TRAPP, BRUCE
|
CLEVELAND CLINIC LERNER COM-CWRU
|
OH
|
$346,719
|
Multiple Sclerosis
|
2015
|
NINDS
|
2R01NS036647-13A1
|
|
The Role of Neurotrophins in Oligodendrocyte Function
|
DREYFUS, CHERYL
|
RBHS-ROBERT WOOD JOHNSON MEDICAL SCHOOL
|
NJ
|
$347,813
|
Multiple Sclerosis
|
2015
|
RMAP
|
3UH3TR000918-03S1
|
|
Exosome RNA-Therapeutics to Promote CNS Myelination
|
KRAIG, RICHARD
|
UNIVERSITY OF CHICAGO
|
IL
|
$79,000
|
Multiple Sclerosis
|
2015
|
NIAID
|
7R01AI067846-10
|
|
Role of BCL11B in CD4+ T Cells
|
AVRAM, DORINA
|
UNIVERSITY OF FLORIDA
|
FL
|
$372,398
|
Multiple Sclerosis
|
2015
|
NIAID
|
4R00AI110649-02
|
|
Molecular signatures of high salt induced pathogenic T cells
|
WU, CHUAN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$249,000
|
Multiple Sclerosis
|
2015
|
NIAID
|
7R21AI107238-03
|
|
Role of Commensal Microbiota in Stressor-Induced Immunomodulation
|
BAILEY, MICHAEL
|
RESEARCH INST NATIONWIDE CHILDREN'S HOSP
|
OH
|
$105,451
|
Multiple Sclerosis
|
2015
|
NIAID
|
3R01AI104519-03S1
|
|
Signaling functions of Peli family of E3 ubiquitin ligases
|
SUN, SHAO-CONG
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
TX
|
$65,984
|
|